« Back to Record
Citation APA

Chatzipli, A., Bonnefoi, H., MacGrogan, G., Sentis, J., Cameron, D. A., Poncet, C., Abadie-Lacourtoisie, S., Bodmer, A., Brain, E., Cufer, T., Campone, M., Luporsi, É. E., Moldovan, C., Petit, T., Piccart-Gebhart, M., Priou, F., Senkus, E., Zaman, K., & Iggo, R. (2021). Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer. British Journal of Cancer. doi:10.1038/s41416-021-01526-3


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/332331

Chatzipli, A., Bonnefoi, H., MacGrogan, G., Sentis, J., Cameron, D. A., Poncet, C., Abadie-Lacourtoisie, S., Bodmer, A., Brain, E., Cufer, T., Campone, M., Luporsi, É. E., Moldovan, C., Petit, T., Piccart-Gebhart, M., Priou, F., Senkus, E., Zaman, K., & Iggo, R. (2021). Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer. British Journal of Cancer. doi:10.1038/s41416-021-01526-3